Literature DB >> 28761462

Subtypes Distribution and Frequency of Blastocystis sp. Isolated from Diarrheic and Non-diarrheic Patients.

Nahid Jalallou1, Shahrokh Iravani2, Mostafa Rezaeian3, Atefe Alinaghizade3, Hamed Mirjalali1,4.   

Abstract

BACKGROUND: Blastocystis is one of the most common parasites, reported from both human and animals. This parasite is more prevalent in regions with low levels of hygiene, close contact with animal and unsuitable disposal systems. The aim of the study was to subtype Blastocystis sp., isolated from diarrheic and non-diarrheic patients using sequencing of 18S ribosomal DNA.
METHODS: Totally, 300 stool samples were collected from diarrheic and nondiarrheic patients referred to Imam Reza Hospital, Tehran from Apr to Aug 2015. All samples were concentrated using conventional Formalin - ether technique and recognized under light microscope. The fresh stool samples were also cultivated in clotted fetal bovine medium and examined for growing of Blastocystis every 48 h with direct smear slides for 10 d. DNA extraction was performed on all positive samples. Amplified DNA fragment of 18S rDNA was sequenced and compared with reference genes, previously deposited in Genbank database.
RESULTS: The number of diarrheic and non-diarrheic patients participated in the study was 134 (44.66%) and 166 (55.34%), respectively. Three subtypes 1, 2, 3 were identified from positive samples. Subtype 2 was the most prevalent (36.5%) followed by subtype 1 (33.3%) and subtype 3 (30.2%). There were no mixed subtypes. Furthermore, the most prevalent subtypes in diarrheic and non-diarrheic patients were subtype 2 (39.28%) and subtype 1 (37.14%), respectively.
CONCLUSION: Blastocystis sp., is one of the most prevalent unicellular parasites among diarrheic and non-diarrheic patients. Indeed, ST2 was the most prevalent subtype particularly in those samples collected from diarrheic patients.

Entities:  

Keywords:  18S rDNA; Blastocystis sp.; Iran; Subtyping

Year:  2017        PMID: 28761462      PMCID: PMC5522700     

Source DB:  PubMed          Journal:  Iran J Parasitol        ISSN: 1735-7020            Impact factor:   1.012


Introduction

Blastocystis sp. is a controversially unicellular parasite reporting from gastrointestinal tract of symptomatic and asymptomatic subjects (1, 2). This unicellular protozoan is one of the most common parasites, all over the world and is reported from both human and animals (3). Fecal-oral is known as the main rout of transmission of the parasite, but, the actual source of transmission has not been clearly known (4–6). The prevalence rate of Blastocystis is different according to the study area and population as well as the method of detection (7). However, the parasite is more prevalent in regions with low levels of hygiene, close contact with animal and unsuitable disposal systems (3). Although, the pathogenic role of Blastocystis is vague, an eventual linkage has been suggested between symptoms and different subtypes of Blastocystis (8). Several studies have described correlation between existence of the parasite and some disorders such as abdominal pain (9, 10), diarrhea and constipation (11, 12), Inflammatory Bowel Syndrome (IBS) (13–15) and recently urticarial (16, 17). Based on polymorphic region of Small Subunit ribosomal DNA (SSU rDNA), 17 subtypes have been introduced in which nine of them have been reported from human (18, 19). Therefore, this discriminative region of rDNA has used for analysis of different epidemiological studies (20, 21). In Iran, description of molecular distribution of Blastocystis subtypes was carried out around different regions of the country. All studies in Iran were performed using PCR-RFLP (22) and sequences tagged-size primers (STS) (23, 24). Primers selection, number and place of mutations, and mixed subtypes are the limitations of RFLP approach (3). On the other hand, STS primers are less sensitivity compared to amplifying 18S rDNA of Blastocystis (7). The present study is the first one that frequency and subtype distribution of Blastocystis sp., was evaluated using amplifying of SSU rDNA in diarrheic and non-diarrheic patients in Iran.

Materials and Methods

Sampling

Three hundred stool samples were collected from diarrheic and non-diarrheic patients referred to Imam Reza Hospital, Tehran, from Apr to Aug 2015. All samples were freshly transferred to the laboratory and were divided into two portions; a portion for microscopical identification and the other portion for cultivation. All samples were concentrated using conventional formalin – ether technique and recognized under light microscope. The study was approved by Ethics Committee of the university and informed consent was taken from all patients.

Culture

The fresh stool samples were cultivated in LE medium as were described (25) with some modification. Briefly, autoclaved 1ml Locke’s solution was added to 2ml slant clotted fetal bovine serum in a screw-cap tube. Then, 200mg from each stool samples together starch and 4mg/ml streptomycin were added to each cultivation tube. All samples were incubated at 37 °C and anaerobic condition for 10 days. Each culture was examined for growing of Blastocystis every 48 h with direct smear slides for 10 days. The cultures that the parasite was not seen in them after 10 days, reported as negative.

DNA extraction PCR and subtyping

Totally, 250 μl of liquid phase of medium of each positive sample was transferred to 1.5 ml tube and was centrifuged at 5000 rpm for 5 min. Then, supernatant was discarded, and the pellet was introduced to i-genomic stool DNA Extraction kit (TECH DRAGON LIMITED, Hong Kong). Purified DNA was stored at −20 °C until use. DNA amplification was performed on all positive samples using 18S rDNA specific primers, described elsewhere including F1 (5′-GGA GGT AGT GAC AAT AAA TC-3′) (26) and BHCRseq3 (5′-TAA GAC TAC GAG GGT ATC TA-3′) (7). The primers amplified a 550 bp fragment of SSU rDNA of Blastocystis sp., specifically according to following protocol: denaturation at 95 °C for 7 min, 35 cycles at 94 °C for 60 sec, 56 °C for 45 sec, 72 °C for 45 sec, followed by a final extension at 72 °C for 7 min. Subsequently, 10 μL of each PCR product was electrophoresed on a 1.5% agarose gel in TBE (0.09M Tris, 0.09 M boric acid, 2 mM EDTA) stained with 0.5 μg/mL ethidium bromide and visualized using a UV Transilluminator. Finally, an ABI (3130) sequencer (California, USA) sequenced 20 μL of all PCR products and the results were compared with those available in GenBank database.

Results

Seventy one (23.7%) and 229 (76.3%) of studied individuals were female and male, respectively. Of 300 stool samples, Blastocystis sp. was observed from 55 (18.3%) and 63 (21%) samples of formalin-ether concentration and cultures, respectively. The mean± Std. Deviation of age of enrolled patients was 42.77± 17.53 and subjects with age ≥ 70 yr old were seen infected with Blastocystis sp., more than other patients. The number of diarrheic and non-diarrheic patients included in the study was 134 (44.66%) and 166 (55.34%), respectively (Table 1).
Table 1:

Frequency of Blastocystis spp., identified by conventional formalin-ether and Cultivation in diarrheic and non-diarrheic patients

VariableFormalin – ether no. (%)Cultivation no. (%)
PositiveNegativePositiveNegative
Diarrheic patients26 (19.41%)108 (80.59%)28 (20.9%)106 (79.1%)
Non-diarrheic patients29 (17.47%)137 (82.53%)35 (21.09%)131 (78.91%)
Total55(18.3)245(81.7)63(21)237(79)
Frequency of Blastocystis spp., identified by conventional formalin-ether and Cultivation in diarrheic and non-diarrheic patients All sequences were edited and then compared with sequences that were already available in GenBank database. Three subtypes 1, 2, 3 were identified from all positive samples using PCR and sequencing of the 18S rDNA. Subtype 2 was the most prevalent (36.5%) followed by subtype 1 (33.3%) and subtype 3 (30.2%). There were no mixed subtypes and the most prevalent subtypes in diarrheic and non-diarrheic patients were subtype 2 (39.28%) and subtype 1 (37.14%), respectively (Table 2).
Table 2:

Subtypes frequency of Blastocystis spp., isolated from diarrheic and non-diarrheic patients

VariableDiarrheic patientsNon diarrheic patientsTotal No. (%)
Subtype 181321 (33.3)
Subtype 2111223 (36.5)
Subtype 391019 (30.2)
Mixed subtypesnonenoneNone
Total283563
Subtypes frequency of Blastocystis spp., isolated from diarrheic and non-diarrheic patients

Discussion

Blastocystis spp. is one of the most prevalent parasites, frequently reported from human and animals (3). Several studies have shown moderate to high prevalence rate of this parasite in Iran (27, 28), but recently, have been seen a growing interest into study on genetic diversity and heterogeneity of Blastocystis in symptomatic and asymptomatic patients. In our study, Blastocystis was observed in 21% of the samples, cultivated in LE medium. Epidemiological studies in Iran have shown that the prevalence rate of the parasite is from about 2% to 29% in both symptomatic and/or asymptomatic individuals. Almost all of these studies have been performed using direct smear slide and iodine staining, while cultivation of Blastocystis increases the sensitivity of detection. Our finding is in agreement with Moosavi and colleagues study that showed higher prevalence of Blastocystis in culture medium compared to microscopic method (23). In another study, Badparva and colleagues reported prevalence rate 6.5% among patients referred to hospital (24) that is more likely related to the subject that cultivation increases the chance of detection of Blastocystis. In this study, subtypes 1, 2 and 3 were obtained from diarrheic and none-diarrheic patients. These subtypes are the most prevalent subtypes reported from other studies in Iran as well as other countries (21, 29). A study on Indian population showed that ST3 was the most common subtypes followed by ST1 (20). In Libya, ST1 was the predominant subtype, while ST2 and ST3 had lesser prevalence (30). In our study, ST2 was the predominant followed by ST1 and ST3. Based on PCR-RFLP approaches, ST1 was the most common subtype in south of Iran (22) while, in another study based on STS primers, ST3 was the dominant subtype (23, 24). Some studies have showed that the prevalence of ST1 in symptomatic and IBS patients is higher than other STs and thus, this subtype was described that as a pathogenic subtype (31, 32), but a clear association between Blastocystis STs and different clinical manifestations has not still been established. However, in our study ST2 was the dominant subtype among patients with diarrhea, while ST1 was the most common subtype in none-diarrheic patients. Although, ST1 was not reported as dominant subtype in Lebanese patients, but ST1 was significantly more prevalent among GI patients (33). On the other hand, potential linkage between ST2 and asymptomatic patients was previously described in Turkey (34). In the current study, despite of majority of ST2 in diarrheic and ST1 in non-diarrheic patients, but there was not seen a statistically correlation between subtypes and gastrointestinal (GI) symptoms like diarrhea. This finding is supported by previous studies showing unclear linkage between certain subtypes of Blastocystis and GI disorders (35, 36). However, molecular study on distribution of Blastocystis subtypes among different human and animals populations is needed to clarify the rout of transmission and potential pathogenic role of Blastocystis.

Conclusion

Blastocystis sp. is one of the most prevalent unicellular parasites among diarrheic and nondiarrheic patients and ST2 was the commonest subtype in positive samples particularly, those samples collected from diarrheic patients.
  35 in total

1.  Extensive genetic diversity in Blastocystis hominis.

Authors:  C G Clark
Journal:  Mol Biochem Parasitol       Date:  1997-07       Impact factor: 1.759

2.  Prevalence and subtype analysis of Blastocystis in healthy Indian individuals.

Authors:  Prashant Kumar Pandey; Pankaj Verma; Nachiket Marathe; Sudarshan Shetty; Ashish Bavdekar; Milind Shivaji Patole; Christen Rune Stensvold; Yogesh Shreepad Shouche
Journal:  Infect Genet Evol       Date:  2015-02-17       Impact factor: 3.342

3.  Blastocystis hominis--an emerging and imitating cause of acute abdomen in children.

Authors:  Nesibe Andiran; Ziya Cibali Acikgoz; Sadi Turkay; Fatih Andiran
Journal:  J Pediatr Surg       Date:  2006-08       Impact factor: 2.545

4.  Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study.

Authors:  C Rune Stensvold; Maiken C Arendrup; Cathrine Jespersgaard; Kåre Mølbak; Henrik V Nielsen
Journal:  Diagn Microbiol Infect Dis       Date:  2007-10-29       Impact factor: 2.803

5.  Molecular epidemiology of Blastocystis infections in Turkey.

Authors:  Mustafa Ozyurt; Ozgür Kurt; Kåre Mølbak; Henrik Vedel Nielsen; Tuncer Haznedaroglu; Christen Rune Stensvold
Journal:  Parasitol Int       Date:  2008-02-13       Impact factor: 2.230

6.  Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats.

Authors:  Eman M Hussein; Abdalla M Hussein; Mohamed M Eida; Maha M Atwa
Journal:  Parasitol Res       Date:  2008-01-11       Impact factor: 2.289

7.  Molecular epidemiology of human Blastocystis in a village in Yunnan province, China.

Authors:  Lan-Hua Li; Xiao-Nong Zhou; Zun-Wei Du; Xue-Zhong Wang; Li-Bo Wang; Jin-Yong Jiang; Hisao Yoshikawa; Peter Steinmann; Jürg Utzinger; Zhiliang Wu; Jia-Xu Chen; Shao-Hong Chen; Ling Zhang
Journal:  Parasitol Int       Date:  2007-06-14       Impact factor: 2.230

8.  Clinical significance and prevalence of Blastocystis hominis in Van, Turkey.

Authors:  Yunus E Beyhan; Hasan Yilmaz; Zeynep T Cengiz; Abdurrahman Ekici
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484

9.  Blastocystis sp.: waterborne zoonotic organism, a possibility?

Authors:  Li Ii Lee; Tan Tian Chye; Biraj Man Karmacharya; Suresh Kumar Govind
Journal:  Parasit Vectors       Date:  2012-06-28       Impact factor: 3.876

10.  Subtype distribution of Blastocystis isolates in Sebha, Libya.

Authors:  Awatif M Abdulsalam; Init Ithoi; Hesham M Al-Mekhlafi; Abdulsalam M Al-Mekhlafi; Abdulhamid Ahmed; Johari Surin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  14 in total

1.  Development and evaluation of high-resolution melting curve analysis for rapid detection and subtyping of Blastocystis and comparison the results with sequencing.

Authors:  Hanieh Mohammad Rahimi; Hamed Mirjalali; Maryam Niyyati; Ali Haghighi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Parasitol Res       Date:  2019-11-05       Impact factor: 2.289

Review 2.  Comparative molecular prevalence and subtypes distribution of Blastocystis sp. a potentially zoonotic infection isolated from symptomatic and asymptomatic patients in Iran: A systematic review and meta-analysis.

Authors:  Ali Asghari; Soheil Hassanipour; Gholamreza Hatam
Journal:  Acta Parasitol       Date:  2021-03-09       Impact factor: 1.440

3.  Molecular characterization and identification of Blastocystis and its subtypes from raccoon (Procyon lotor) in north of Iran.

Authors:  Hanieh Mohammad Rahimi; Sara Nemati; Hamed Mirjalali; Meysam Sharifdini; Mohammad Reza Zali
Journal:  Parasitol Res       Date:  2020-06-24       Impact factor: 2.289

4.  Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran.

Authors:  H Mirjalali; M R Abbasi; N Naderi; Z Hasani; E S Mirsamadi; C R Stensvold; H Balaii; H Asadzadeh Aghdaei; M R Zali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-25       Impact factor: 3.267

5.  Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.

Authors:  Masoumeh Azimirad; Sara Mohammad Ali Gol; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Shabnam Shahrokh; Hedieh Balaii; Amir Sadeghi; Mohammad Reza Zali
Journal:  Turk J Gastroenterol       Date:  2021-06       Impact factor: 1.852

6.  High occurrence of Blastocystis sp. subtype 3 in individuals referred to medical laboratories in Kermanshah, Iran.

Authors:  Bahman Maleki; Javid Sadraei; Abdolhossein Dalimi Asl; Majid Pirestani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

7.  Molecular epidemiology of Blastocystis spp. in children referred to Qods hospital in northwest of Iran.

Authors:  Soheila Rahimi Niaraki; Elham Hajialilo; Asma Delshad; Safar Ali Alizadeh; Mahmood Alipour; Peyman Heydarian; Mehrzad Saraei
Journal:  J Parasit Dis       Date:  2019-11-25

8.  Association between Blastocystis and body mass index in healthy subjects; a theoretical pilot study.

Authors:  Hamed Mirjalali; Asal Latifi; Ali Taghipour; Abbas Yadegar; Behzad Hatami; Amir Sadeghi; Mohammad Javad Ehsani; Mohammad Reza Zali
Journal:  J Diabetes Metab Disord       Date:  2020-01-03

9.  Prevalence and subtype identification of Blastocystis isolated from humans in Ahvaz, Southwestern Iran.

Authors:  Roya Salehi; Ali Haghighi; C Rune Stensvold; Farnaz Kheirandish; Eznelloah Azargashb; Saber Raeghi; Cobra Kohansal; Fares Bahrami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

10.  Study of prevalence, distribution and clinical significance of Blastocystis isolated from two medical centers in Iran.

Authors:  Tahereh Rezaei Riabi; Ali Haghighi; Hamed Mirjalali; Sara Mohammad Ali Gol; Seyed Ahmad Karamati; Mehrdad Ghasemian; Ayat Bahadori Monfared; Elham Aghamohammadi; Homayoun Zojaji
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.